Results 251 to 260 of about 2,716,569 (343)
The role of obesity and Type 2 diabetes in lung health: A systematic review (2024). [PDF]
Lecky R +5 more
europepmc +1 more source
This study develops a placenta‐targeted nanodelivery system co‐loading HMGB1 protein and the NLRP3 agonist nigericin to establish an animal model of atonic postpartum hemorrhage. The model accurately recapitulates clinical phenotypes, including prolonged labor and uterine contractility dysfunction, while revealing inflammatory activation in placental ...
Jiangxue Qu +10 more
wiley +1 more source
Correction to 'Insights Into the Management of Type 2 Diabetes at Diagnosis in Spain: The NEW2TYPE2 Study'. [PDF]
europepmc +1 more source
Sleep Quality in Patients With Type 2 Diabetes Mellitus. [PDF]
Khamassi S +5 more
europepmc +1 more source
Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández +4 more
wiley +1 more source
Precision prevention in type 2 diabetes
Magdalena Sevilla-Gonzalez
doaj +1 more source
The effect of antidepressant medication use on HbA1c levels in type 2 diabetes. [PDF]
Saglam F, Nas N, Saglik S.
europepmc +1 more source
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales +11 more
wiley +1 more source
Editorial: (Un)healthy lifestyles, aging, and type 2 diabetes. [PDF]
Duarte-Mendes P, Silva FM, Teixeira AM.
europepmc +1 more source

